Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
News Article updated on 10/01/2021
-
HAB Releases New Policy Notice Simplifying Core Medical Services Waiver Requirements
From HRSA's HIV/AIDS Bureau - 10/1/2021 - Dear Ryan White HIV/AIDS Program Colleagues:
News Article updated on 10/04/2021 -
Four Things to Know About Open Enrollment 2022
-
Ryan White Part A-F Awards Announced for FY21
From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/5/21
News Article updated on 10/06/2021 -
Peer Engagement to Improve Linkage to Care and Retention in Care for Women and Youth
University Health uses peers and patient navigators to provide support, reduce barriers, and improve linkage and retention to care for women and youth with HIV. Two peers with lived experience were hired as Outreach Specialists to spearhead the program, encourage medication adherence and use of services, and provide mentoring. The intervention was successful in moderately improving the numbers of clients linked to care, retained in care, and virally suppressed.Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
-
Early Intervention Services and Outreach
The Oregon Health Authority awarded contracts to local public health authorities across the state to work with community partners to integrate early intervention services and outreach services, link people to HIV care, and provide support to help clients reach viral suppression. Quick linkage to care resulted in a median of 57 days to viral suppression for Early Intervention Services and Outreach clients in 2019.Resource from the RWHAP Best Practices Compilation updated on 05/14/2024
-
EHE Jurisdictional Directory
List of local and state EHE points of contact.Resource updated 03/28/2024
-
Office Hours: A New TA Platform for Data Support
From the DISQ Listserv - Dear RWHAP community
News Article updated on 09/10/2021 -
EHE Resource Recap, October 2021
HHS has funded multiple agencies to deliver technical assistance and training to Ending the HIV Epid
News Article updated on 10/18/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
HRSA EHE Quarterly Recipient Webinars
These sessions provide HRSA-HAB funded EHE recipients the opportunity to learn about updates with the initiative, review data trends, and a means to share their EHE activities with their counterparts.Resource updated 06/13/2024
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Needs Assessment Tool Series: Focus Groups
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Online Course on Integrated Planning
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023